Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...

While Elon Musk’s Neuralink is the most well-funded of the group, other companies working on computer-brain interfaces have ...

The market outlook from the perspective of many biotech CEOs is grim. When the investment environment stabilized following a ...

Tolerance Bio is targeting an often-overlooked organ — the thymus — with cell therapy to help kids with DiGeorge syndrome, and potentially extend lifespan in adults.

California, United States Blockchain Builders, a venture fund embedded in the Stanford blockchain ecosystem, has announced ...

The University of Hull has joined forces with Polaroid Therapeutics (PTx), the leading Swiss biotech company, to launch the ...

In a strong show of support for next-generation crypto innovation, a group of Stanford graduate students has announced the ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

LOS ANGELES] Venture-backed startups are staying private for longer – and growing so much bigger – that they are starting to ...